CCL19/CCR7 drives regulatory T cell migration and indicates poor prognosis in gastric cancer

Abstract Background Gastric cancer is associated with significant morbidity and mortality in the world. Blocking programmed cell death protein 1 pathway have been approved for the treatment of a variety of tumors and have achieved remarkable clinical therapeutic effects. However, immune checkpoint i...

Full description

Bibliographic Details
Main Authors: Danhua Xu, Xu Liu, Shouyu Ke, Yixian Guo, Chunchao Zhu, Hui Cao
Format: Article
Language:English
Published: BMC 2023-05-01
Series:BMC Cancer
Subjects:
Online Access:https://doi.org/10.1186/s12885-023-10882-7
_version_ 1827943403205165056
author Danhua Xu
Xu Liu
Shouyu Ke
Yixian Guo
Chunchao Zhu
Hui Cao
author_facet Danhua Xu
Xu Liu
Shouyu Ke
Yixian Guo
Chunchao Zhu
Hui Cao
author_sort Danhua Xu
collection DOAJ
description Abstract Background Gastric cancer is associated with significant morbidity and mortality in the world. Blocking programmed cell death protein 1 pathway have been approved for the treatment of a variety of tumors and have achieved remarkable clinical therapeutic effects. However, immune checkpoint inhibitors failed to achieve satisfactory results in gastric cancer. There is a need to identify novel immunotherapy targets in gastric cancer. Methods We analysed the correlation between Treg cells and CD8 + T cells in gastric cancer samples. We studied the relationship between chemokines and Treg cells or CD8 + T cells in gastric cancer. We compared CCL19/CCR7 expression in gastric cancer patients in TCGA database. We performed transwell experiments to determine the influence of CCL19 on Treg cells and CD8 + T cells migratory capacity. We conducted survival analysis of CCL19 and CCR7 in gastric cancer database. Results Treg cells show positive correlation with CD8 + T cells in gastric cancer. Treg cell expression was significantly upregulated in tumor tissues. Patients with high FOXP3 expression had worse overall survival than those with low FOXP3 expression. CCL19 had strong correlation with FOXP3 and weak correlation with CD8A. CCL19 had strong impact on the migratory capacity of Treg cells but weak impact on the migratory capacity of CD8 + T cells. Both CCL19 and CCR7 expression were significantly upregulated in gastric cancer tissues. Survival analysis demonstrated that both CCL19 and CCR7 indicate poor prognosis in gastric cancer. Conclusions CCL19/CCR7 may be a potential novel therapeutic target in gastric cancer.
first_indexed 2024-03-13T10:14:57Z
format Article
id doaj.art-b03e36c6b68545cea0bdd2a89b94cd20
institution Directory Open Access Journal
issn 1471-2407
language English
last_indexed 2024-03-13T10:14:57Z
publishDate 2023-05-01
publisher BMC
record_format Article
series BMC Cancer
spelling doaj.art-b03e36c6b68545cea0bdd2a89b94cd202023-05-21T11:18:40ZengBMCBMC Cancer1471-24072023-05-012311810.1186/s12885-023-10882-7CCL19/CCR7 drives regulatory T cell migration and indicates poor prognosis in gastric cancerDanhua Xu0Xu Liu1Shouyu Ke2Yixian Guo3Chunchao Zhu4Hui Cao5Department of Gastrointestinal Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong UniversityDepartment of Gastrointestinal Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong UniversityDepartment of Gastrointestinal Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong UniversityDepartment of Gastrointestinal Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong UniversityDepartment of Gastrointestinal Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong UniversityDepartment of Gastrointestinal Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong UniversityAbstract Background Gastric cancer is associated with significant morbidity and mortality in the world. Blocking programmed cell death protein 1 pathway have been approved for the treatment of a variety of tumors and have achieved remarkable clinical therapeutic effects. However, immune checkpoint inhibitors failed to achieve satisfactory results in gastric cancer. There is a need to identify novel immunotherapy targets in gastric cancer. Methods We analysed the correlation between Treg cells and CD8 + T cells in gastric cancer samples. We studied the relationship between chemokines and Treg cells or CD8 + T cells in gastric cancer. We compared CCL19/CCR7 expression in gastric cancer patients in TCGA database. We performed transwell experiments to determine the influence of CCL19 on Treg cells and CD8 + T cells migratory capacity. We conducted survival analysis of CCL19 and CCR7 in gastric cancer database. Results Treg cells show positive correlation with CD8 + T cells in gastric cancer. Treg cell expression was significantly upregulated in tumor tissues. Patients with high FOXP3 expression had worse overall survival than those with low FOXP3 expression. CCL19 had strong correlation with FOXP3 and weak correlation with CD8A. CCL19 had strong impact on the migratory capacity of Treg cells but weak impact on the migratory capacity of CD8 + T cells. Both CCL19 and CCR7 expression were significantly upregulated in gastric cancer tissues. Survival analysis demonstrated that both CCL19 and CCR7 indicate poor prognosis in gastric cancer. Conclusions CCL19/CCR7 may be a potential novel therapeutic target in gastric cancer.https://doi.org/10.1186/s12885-023-10882-7ChemokinesCCL19CCR7Treg cellsCD8 + T cellsGastric cancer
spellingShingle Danhua Xu
Xu Liu
Shouyu Ke
Yixian Guo
Chunchao Zhu
Hui Cao
CCL19/CCR7 drives regulatory T cell migration and indicates poor prognosis in gastric cancer
BMC Cancer
Chemokines
CCL19
CCR7
Treg cells
CD8 + T cells
Gastric cancer
title CCL19/CCR7 drives regulatory T cell migration and indicates poor prognosis in gastric cancer
title_full CCL19/CCR7 drives regulatory T cell migration and indicates poor prognosis in gastric cancer
title_fullStr CCL19/CCR7 drives regulatory T cell migration and indicates poor prognosis in gastric cancer
title_full_unstemmed CCL19/CCR7 drives regulatory T cell migration and indicates poor prognosis in gastric cancer
title_short CCL19/CCR7 drives regulatory T cell migration and indicates poor prognosis in gastric cancer
title_sort ccl19 ccr7 drives regulatory t cell migration and indicates poor prognosis in gastric cancer
topic Chemokines
CCL19
CCR7
Treg cells
CD8 + T cells
Gastric cancer
url https://doi.org/10.1186/s12885-023-10882-7
work_keys_str_mv AT danhuaxu ccl19ccr7drivesregulatorytcellmigrationandindicatespoorprognosisingastriccancer
AT xuliu ccl19ccr7drivesregulatorytcellmigrationandindicatespoorprognosisingastriccancer
AT shouyuke ccl19ccr7drivesregulatorytcellmigrationandindicatespoorprognosisingastriccancer
AT yixianguo ccl19ccr7drivesregulatorytcellmigrationandindicatespoorprognosisingastriccancer
AT chunchaozhu ccl19ccr7drivesregulatorytcellmigrationandindicatespoorprognosisingastriccancer
AT huicao ccl19ccr7drivesregulatorytcellmigrationandindicatespoorprognosisingastriccancer